CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,596 enrolled
Drug / intervention
Electronic Alertother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04394715
NCT04394715N/ACompleted

Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

Yale University·interventional·Posted May 19, 2020·Updated Sep 3, 2024

In Brief

A clinical study evaluating Electronic Alert for High Risk Atherosclerotic Cardiovascular Disease. Completed, enrolled 2,596 participants across 4 sites.

Detailed Summary

This study is designed to evaluate the efficacy of automated electronic alerts in the electronic health record to improve rates of best practices in the treatment of patients with hyperlipidemia who present in the setting of outpatient primary care and family medicine practices within the Yale New Haven Health System.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 19, 2020
Enrollment StartJun 1, 2021
Primary CompletionJun 9, 2022
Study CompletionSep 9, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.1 years ago

Interventions

Electronic Alertother

Providers will see an automated electronic alert for each eligible hyperlipidemia patient at high risk for future atherosclerotic CVD events. This alert will appear when the provider enters the order entry screen in the patient's medical record during the patient's first eligible outpatient visit. The alert consists of a "pop up" that notifies the physician that the patient is at very high risk for ASCVD events, displays the most recent cholesterol values and the patient's current lipid lowering therapy. It also includes a link to full treatment guidelines for hyperlipidemia, which includes a continuing medical education (CME) option to obtain CME credits.